Detalhe da pesquisa
1.
BRCA gene amplification in primary peritoneal high-grade serous carcinoma patient with intrinsic resistance to platinum treatment: a case report.
Pathologica
; 115(2): 107-110, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-37114628
2.
POLE exonuclease domain mutations in endometrial carcinoma: a case report.
Pathologica
; 1(1): 181-185, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-37216304
3.
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation.
Cancer Immunol Immunother
; 71(4): 865-874, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-34462870
4.
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort.
J Transl Med
; 19(1): 270, 2021 06 24.
Artigo
Inglês
| MEDLINE | ID: mdl-34167578
5.
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice.
J Transl Med
; 17(1): 376, 2019 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31730009
6.
A retrospective observational study on cutaneous adverse events induced by immune checkpoint inhibitors.
Ital J Dermatol Venerol
; 158(6): 437-444, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-38015482
7.
Prognostic value of gender and primary tumor location in metastatic colon cancer.
J Cancer
; 14(15): 2751-2758, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37781086
8.
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.
Clin Cancer Res
; 29(14): 2714-2724, 2023 07 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37125965
9.
Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer.
Onco Targets Ther
; 15: 407-410, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35431558
10.
High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study.
Cancers (Basel)
; 14(19)2022 Sep 29.
Artigo
Inglês
| MEDLINE | ID: mdl-36230671
11.
Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis.
Front Oncol
; 12: 935826, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36033477
12.
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status.
J Hematol Oncol
; 15(1): 9, 2022 01 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35062993
13.
Retroperitoneal extension of massive ulcerated testicular seminoma through the inguinal canal: A case report.
Arch Ital Urol Androl
; 93(1): 64-67, 2021 Mar 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33754611
14.
Phenotypic and Proteomic Analysis Identifies Hallmarks of Blood Circulating Extracellular Vesicles in NSCLC Responders to Immune Checkpoint Inhibitors.
Cancers (Basel)
; 13(4)2021 Feb 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33546102
15.
Tgf-ß1 transcriptionally promotes 90K expression: possible implications for cancer progression.
Cell Death Discov
; 7(1): 86, 2021 Apr 22.
Artigo
Inglês
| MEDLINE | ID: mdl-33888686
16.
Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Front Oncol
; 11: 712053, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34778029
17.
Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy.
Eur J Cancer
; 150: 224-231, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33934059
18.
Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case-control matched analysis from a large multicenter study.
Thorac Cancer
; 12(6): 880-889, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33527756
19.
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy.
J Immunother Cancer
; 9(4)2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33827906
20.
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index.
Eur J Cancer
; 142: 18-28, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33212418